Table 3. Significantly dysregulated lncRNAs in paired tumor and adjacent normal analysis.
| Pairwise tumor versus adjacent normal | ||||
|---|---|---|---|---|
| Fold change | logCPM | P value | FDR | |
| lnc-AKR1B10-1:1 | 14.17 | 7.42 | 9.48E-10 | 6.80E-09 |
| lnc-ASPM-1:4 | 14.10 | 2.13 | 2.04E-60 | 3.85E-57 |
| lnc-ASPM-1:5 | 14.10 | 2.13 | 2.04E-60 | 3.85E-57 |
| lnc-BEST4-1:1 | 11.69 | 2.68 | 5.71E-40 | 2.46E-37 |
| lnc-FABP6-4:1 | 11.03 | 3.69 | 8.75E-27 | 9.86E-25 |
| lnc-CXCL12-4:2 | −16.08 | 2.47 | 1.08E-40 | 5.04E-38 |
| lnc-TARS2-1:2 | −16.10 | 2.18 | 1.94E-44 | 1.36E-41 |
| lnc-SEC22C-1:4 | −16.15 | 1.82 | 6.77E-41 | 3.24E-38 |
| lnc-EIF2AK3-4:9 | −16.25 | 1.68 | 5.69E-15 | 1.02E-13 |
| lnc-SEC22C-1:12 | −16.27 | 1.53 | 1.75E-41 | 9.11E-39 |